These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7578407)

  • 41. Transcriptional regulation of the carcinoembryonic antigen gene. Identification of regulatory elements and multiple nuclear factors.
    Hauck W; Stanners CP
    J Biol Chem; 1995 Feb; 270(8):3602-10. PubMed ID: 7876096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Provision of positive and negative selections in retroviral vectors containing the cytosine deaminase gene.
    Shiau AL; Yang HM; Wu P; Wu CL
    Gene Ther; 1998 Nov; 5(11):1571-4. PubMed ID: 9930312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone-dependent regulation of intercellular adhesion molecule-1 gene expression: cloning and analysis of 5'-regulatory region of rat intercellular adhesion molecule-1 gene in FRTL-5 rat thyroid cells.
    Park ES; You SH; Kim H; Kwon OY; Ro HK; Cho BY; Taniguchi SI; Kohn LD; Shong M
    Thyroid; 1999 Jun; 9(6):601-12. PubMed ID: 10411124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
    Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.
    Austin EA; Huber BE
    Mol Pharmacol; 1993 Mar; 43(3):380-7. PubMed ID: 8450832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma.
    Ju DW; Tao Q; Cheng DS; Zhang W; Zhang M; Hamada H; Cao X
    Gene Ther; 2000 Feb; 7(4):329-38. PubMed ID: 10694814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
    Mullen CA; Coale MM; Lowe R; Blaese RM
    Cancer Res; 1994 Mar; 54(6):1503-6. PubMed ID: 8137255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization.
    Rogulski KR; Wing MS; Paielli DL; Gilbert JD; Kim JH; Freytag SO
    Hum Gene Ther; 2000 Jan; 11(1):67-76. PubMed ID: 10646640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA sequences and their binding proteins required for Sertoli cell-specific transcription of the rat androgen-binding protein gene.
    Fenstermacher DA; Joseph DR
    Mol Endocrinol; 1997 Aug; 11(9):1387-400. PubMed ID: 9259328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
    Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
    Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A carcinoembryonic antigen polynucleotide vaccine for human clinical use.
    Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Pike J; Curiel DT
    Cancer Gene Ther; 1995 Mar; 2(1):33-8. PubMed ID: 7621253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific Colon Cancer Cell Cytotoxicity Induced by Bacteriophage E Gene Expression under Transcriptional Control of Carcinoembryonic Antigen Promoter.
    Rama AR; Hernandez R; Perazzoli G; Burgos M; Melguizo C; Vélez C; Prados J
    Int J Mol Sci; 2015 Jun; 16(6):12601-15. PubMed ID: 26053394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene.
    Hlavatý J; Hlubinová K; Altaner C
    Neoplasma; 1999; 46(5):267-76. PubMed ID: 10665841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
    Cao X; Ju DW; Tao Q; Wang J; Wan T; Wang BM; Zhang W; Hamada H
    Gene Ther; 1998 Aug; 5(8):1130-6. PubMed ID: 10326037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.
    Bräuninger A; Strebhardt K; Rübsamen-Waigmann H
    Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
    Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
    Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.